Back
EHRA Premium Access

Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation

Session: Atrial Fibrillation - Round 1 - Drugs, Prevention
Topic: Diagnostic Methods
Speaker: Doctor R. Wijesurendra (Oxford, GB)
Event: EHRA 2023

Congress Presentation

About the speaker

Doctor Rohan Wijesurendra

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
5 presentations
0 follower

5 more presentations in this session

Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study

Speaker: Doctor S. Diederichsen (Copenhagen, DK)

Access
Abstract
Slides
Video
Thumbnail

Atrial fibrillation is an independent risk factor for heart failure progression and pump failure mortality in HFpEF:: a propensity score matched analysis of the TOPCAT Americas study

Speaker: Professor D. Shah (Geneva, CH)

Access
Abstract
Slides
Video
Thumbnail

Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)

Speaker: Doctor S. Simovic (Kragujevac, RS)

Access
Abstract
Slides
Video
Thumbnail

Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus

Speaker: Doctor H. Ahn (Seoul, KR)

Access
Abstract
Slides
Video
Thumbnail

Atrial fibrillation and in-hospital mortality in Covid-19 patients

Speaker: Doctor I. Kotadia (London, GB)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Atrial Fibrillation - Round 1 - Drugs, Prevention

Speakers: Doctor R. Wijesurendra, Doctor S. Diederichsen, Professor D. Shah, Doctor S. Simovic, Doctor H. Ahn...
Access
Video
Thumbnail

About the event

Image

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb